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Abstract: Crude extracts and column fractions from the red algae Asparagopsis taxiformis 
and  A.  armata from the Strait of Messina (Italy) were screened for the production of 
antimicrobial compounds. Extracts from both species revealed remarkable antiprotozoal 
activity against Leishmania, revealing such algae as a great source of natural antiprotozoal 
products.  
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1. Introduction 
 
The interest in marine organisms as a potential and promising source of pharmaceutical agents has 
increased during the last years [1–4]. To date, many chemically unique compounds of marine origin 
with various biological activities have been isolated, and some of them are under investigation and are 
being used to develop new pharmaceuticals [5]. 
Some red algae were reported to produce chemicals that have potent biological effects [6,7]. 
Numerous natural products, including halogenated compounds, like haloforms, methanes, ketones, 
acetates and acrylates, were described just from the genus Asparagopsis [8,9]. 
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This genus includes tropical-subtropical red seaweeds, with diplohaplontic life cycle and an 
heteromorphic tetrasporophyte known as the ‘Falkenbergia’ stage. To date the genus is represented in 
the Mediterranean Sea by two species, A. armata and A. taxiformis. A. armata, a temperate distributed 
species, is considered a Lessepsian immigrant, first reported from the Algerian coasts in 1923 [10]. A. 
taxiformis, a tropical to warm temperate species, is considered a pre-Lessepsian immigrant or native in 
the eastern Mediterranean [11], since the first record in the Mediterranean Sea was given in   
Egypt [12]. Both taxa exhibit a strong invasive behaviour and are included in the list of the “Worst 
invasive alien species threatening biodiversity in Europe” (EEA 2007) and also in the list of the 100 
“Worst Invasives in the Mediterranean Sea” [13]. 
A. taxiformis and A. armata, as well as other species of the family Bonnemaisoniaceae are well 
known as sources of halogenated compounds [8,14] with strong antifungal and antibiotic   
activity [8,15]. Dichloromethane extracts obtained from A. armata exhibited a strong activity against 
fish pathogenic bacteria [16]. 
In general, the production of biologically-active metabolites is inherently linked to an ability to 
partition compounds into specialised storage structures in order to avoid autotoxicity [17]. 
Members of the Bonnemaisoniaceae form specialized cells [18–20] typically known as vesicle or 
gland cells [21]. In the tetrasporophyte of A. armata, the halogenated metabolites accumulate as a 
refractile inclusion inside specialized gland cells and this inclusion is no longer produced when the 
alga is cultured without bromine [21]. 
The pungent aroma of these algae is due to an essential oil that is composed mainly of bromoform 
with smaller amounts of other bromine, chlorine, and iodine-containing methane, ethane, ethanol, 
acetaldehydes, acetones, 2-acetoxypropanes, propenes, epoxypropanes, acroleins and butenones [14]. 
The halogenated compounds from Asparagopsis have a wide range of volatility and solubility and, 
hence, no single method of extraction and isolation can be considered entirely satisfactory [8]. 
In the present paper we present data on the production of antimicrobial halogenated compounds on 
crude extracts and column fractions from A. taxiformis and A. armata against Leishmania.  
 
2. Results and Discussion 
 
Three different solvents with increasing polarity were used for the extraction of freeze-dried 
seaweed powder. Our observations of the effects of extraction method on bioactivity revealed that the 
active compounds are probably non polar to moderate polar, since the highest activity was observed in 
ethanol crude extracts fractioned with hexane:ethyl acetate and ethyl acetate. A series of small 
molecular volatile halogenated compounds (halomethanes, haloethers, haloacetals) are described as 
responsible for the antimicrobial action of A. armata [8].  
Hexane and dichloromethane crude extracts of A. taxiformis exhibited a strong inhibition of 
Leishmania. IC50 (half maximal inhibitory concentration) were 17.00 μg/mL and 16.00 μg/mL, for 
both extracts, respectively, and IC90 (90% inhibitory concentration) were 33.00 μg/mL and   
32.00 μg/mL, for both extracts, respectively (Table 1). 
Hexane and dichloromethane crude extracts of A. armata also showed a remarkable inhibition, 
however, both IC50 and IC90 values were low (over 40.00 μg/mL) at the same experimental conditions 
(Table 1). Mar. Drugs 2009, 7  
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The active fractions obtained from ethanol crude extracts of A. taxiformis were eluted with hexane-
ethyl acetate and ethyl acetate. IC50 values were 14.00 μg/mL and 20.00 μg/mL, for both fractions, 
respectively, and IC90 were 32.00 μg/mL and 34.00 μg/mL, for both fractions, respectively (Table 1). 
The same moderate polar fractions from A. armata resulted active with IC50 of 10.00 and   
19.00 μg/mL, IC90 30.00 and 32.00 μg/mL under the same experimental conditions (Table 1). 
Pentamidine and amphotericin B were tested as control drugs. Two different inhibition assays were 
performed. IC50 values ranged from 0.9 to 1.0 mg/mL and IC90s ranged from 1.9 to 4.0 mg/mL for 
pentamidine, while IC50s ranged from 0.18 to 0.19 mg/mL and the IC90 was 0.32 mg/mL for 
amphotericin B (Table 2). 
 
Table 1. Data of IC50 and IC90 (μg/mL) of crude extracts and fractions of A. armata and A. 
taxiformis. HEX: hexane; DCM: dichloromethane; EtOH: ethanol; EtOAc: ethyl acetate; 
MeOH: methanol. 
Species Crude  extract/Fraction  IC50 (μg/mL) IC90 (μg/mL) 
A. armata  HEX >40  >40 
A. armata  DCM >40  >40 
A. armata  EtOH-Hex:EtOAc   10  30 
A. armata  EtOH-EtOAc   19  32 
A. armata  EtOH-EtOAc:MeOH Inactive  Inactive 
A. armata  EtOH-MeOH Inactive  Inactive 
A. armata  EtOH-H2O Inactive  Inactive 
A. taxiformis  HEX 17  33 
A. taxiformis  DCM 16  32 
A. taxiformis  EtOH-Hex:EtOAc   14  32 
A. taxiformis  EtOH-EtOAc   20  34 
A. taxiformis  EtOH-EtOAc:MeOH Inactive  Inactive 
A. taxiformis  EtOH-MeOH Inactive  Inactive 
A. taxiformis  EtOH-H2O Inactive  Inactive 
 
Table 2. Data of IC50 and IC90 (μg/mL) of tested control drugs. 
Control drug   IC50 (mg/mL)  IC90 (mg/mL) 
Pentamidine  from 0.9 to 1  from 1.9 to 4 
Amphotericin B  from 0.18 to 0.19  0.32 
 
Leishmaniasis is a disease caused by the protozoa of the Leishmania species and it has a worldwide 
distribution, especially in many tropical and sub-tropical countries. It affects as many as 12 million 
people worldwide, with 1.5–2 million new cases each year. There is increasing awareness that drug 
treatment can be complicated by variation in the sensitivity of Leishmania species to drugs, variation 
in pharmacokinetics, and variation in drug-host immune response interaction [26,27]. 
The LC-MS analysis of the column fraction in ethyl acetate from ethanol crude extracts of A. 
taxiformis revealed two peaks of nearly the same intensity at m/z 303.1 and 305.1 [M+H], which 
indicates presence of one bromine atom. Due to the small quantities of extracts and fractions, further 
characterization of this compound was not possible. The presence of a small molecular weight Mar. Drugs 2009, 7  
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brominated molecule in the active fraction confirms that the lipophilic halogenated compounds are 
truly the metabolites responsible for potent antimicrobial activity of this extract.  
 
3. Experimental Section  
 
Plants of A. taxiformis and A. armata were collected from the Strait of Messina (Italy), respectively 
at Torre Faro, Messina and Villa San Giovanni, Reggio Calabria in May 2008. Fresh plants were 
washed in sterile sea water and manually cleaned of epiphytes. Lyophilized and powdered plants of A. 
taxiformis and A. armata (dry weights: 75 g for each species) were extracted using different organic 
solvents with increasing polarity (hexane, dichloromethane and ethanol) at room temperature. Extracts 
were dried with a Rotavapor® at low temperature (35 °C) to prevent volatile compounds from 
evaporation.  
In vitro antimicrobial susceptibility assays were performed on Leishmania donovani promastigotes 
cultures (2 × 10
6 cell/mL). A transgenic cell line of L. donovani promastigotes showing stable 
expression of luciferase was used as the test organism. The plates were incubated at 26 °C for 72 h, 
and growth of Leishmania promastigotes was determined by the Alamar blue assay [28]. Pentamidine 
and amphotericine B were tested as the standard antileishmanial agents. Microbiological assays were 
performed at the Microbiology laboratory of National Center For Natural Products Research of the 
University of Mississippi. 
The hexane and dichloromethane extracts were not further fractionated because of limited amount 
of materials. Ethanol extracts of A. taxiformis and A. armata were submitted to fractionation using Si 
gel vacuum liquid chromatography eluted in order with hexane, hexane-ethyl acetate (1:1), ethyl 
acetate, ethyl acetate- methanol (1:1), methanol, water. Fractions were tested in antimicrobial assays.  
Fractionation and isolation of compounds were further performed using HPLC, with a normal phase 
Silica gel column (10 mm) as stationary phase and gradient of two solvents, hexane and isopropanol, 
as mobile phase. Each fraction was dried in vacuum and 
1H-NMR spectra in CDCl3 was recorded on a 
Bruker BioSpin instrument operating at 400 MHz. LC-MS analysis for each sample was carried out 
with a micrOTOF ESI-TOF MS.  
 
4. Conclusions  
 
Red algae of the genus Asparagopsis are well known as sources of halogenated compounds with 
strong antifungal and antibacterial activity [8,14–16], but, as far as we know, there are no published 
data on their activity against any protozoa. According to our results, A. armata and A. taxiformis 
revealed high potential as source of natural products with antiprotozoal activity in vitro. This first 
report of the effectiveness of Asparagopsis against Leishmania represents a challenge to encourage 
explorative research on such topic. Asparagopsis species merit further studies both with the aim of 
isolating their active metabolites on larger scale and for assaying culture methods for supplying algal 
biomass for industry. 
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